Analysis of interleukin-4 receptor α chain variants in multiple sclerosis

被引:16
作者
Hackstein, H
Bitsch, A
Bohnert, A
Hofmann, H
Weber, F
Ohly, A
Linington, C
Mäurer, M
Poser, S
Rieckmam, P
Bein, G
机构
[1] Univ Giessen, Inst Clin Immunol & Transfus Med, D-35392 Giessen, Germany
[2] Univ Gottingen, Dept Neurol, D-37075 Gottingen, Germany
[3] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany
[4] Univ Wurzburg, Dept Neurol, D-97080 Wurzburg, Germany
关键词
human IL-4 receptor; multiple sclerosis; MOG autoantibodies;
D O I
10.1016/S0165-5728(00)00455-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A recent candidate gene study employing microsatellite markers suggested a possible linkage of multiple sclerosis (MS) with the interleukin-4 receptor (IL4R) gene. Consequently, we investigated the association of different IL4R variants with MS in 341 german MS patients and 305 healthy controls. Analysis of the first 100 MS patients for six IL4R variants showed an increased frequency of the R551 variant in MS patients versus healthy controls and carriage of the same IL4R variant was weakly associated with myelin oligodendrocyte glycoprotein (MOG) autoantibody production. However, further analysis of all 341 MS patients did not confirm the finding that this IL4R variant represents a general genetic risk factor for MS but revealed an increased frequency of the R551 Variant in MS patients with primary progressive MS (PPMS, n=48) as compared to patients with relapsing remitting MS or secondary progressive MS (RR/SPMS n=284; P=0.005 for genotype differences) and to 305 healthy controls (P=0.001 for genotype differences). This association was statistically independent of the presence of the well-known MS susceptibility allele HLA-DRB1*15. After correction for multiple comparisons only the genotype differences between PPMS patients and healthy controls remained statistically significant. These results indicate, that the IL4R variant R551 may influence the genetic predisposition for PPMS but does not represent a general genetic risk factor for MS. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:240 / 248
页数:9
相关论文
共 57 条
[1]   The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat [J].
Adelmann, M ;
Wood, J ;
Benzel, I ;
Fiori, P ;
Lassmann, H ;
Matthieu, JM ;
Gardinier, MV ;
Dornmair, K .
JOURNAL OF NEUROIMMUNOLOGY, 1995, 63 (01) :17-27
[2]  
Antonarakis SE, 1998, HUM MUTAT, V11, P1
[3]  
Archelos JJ, 2000, ANN NEUROL, V47, P694, DOI 10.1002/1531-8249(200006)47:6<694::AID-ANA2>3.3.CO
[4]  
2-N
[5]   RAPID HLA-DRB1 GENOTYPING BY NESTED PCR-AMPLIFICATION [J].
BEIN, G ;
GLASER, R ;
KIRCHNER, H .
TISSUE ANTIGENS, 1992, 39 (02) :68-73
[6]   Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG) [J].
Brehm, U ;
Piddlesden, SJ ;
Gardinier, MV ;
Linington, C .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 97 (1-2) :9-15
[7]   The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen [J].
Chataway, J ;
Feakes, R ;
Coraddu, F ;
Gray, J ;
Deans, J ;
Fraser, M ;
Robertson, N ;
Broadley, S ;
Jones, H ;
Clayton, D ;
Goodfellow, P ;
Sawcer, S ;
Compston, A .
BRAIN, 1998, 121 :1869-1887
[8]   HLA typing in the United Kingdom multiple sclerosis genome screen [J].
Coraddu, F ;
Sawcer, S ;
Feakes, R ;
Chataway, J ;
Broadley, S ;
Jones, HB ;
Clayton, D ;
Gray, J ;
Smith, S ;
Taylor, C ;
Goodfellow, PN ;
Compston, A .
NEUROGENETICS, 1998, 2 (01) :24-33
[9]   Common polymorphisms in the coding part of the IL4-receptor gene [J].
Deichmann, K ;
Bardutzky, J ;
Forster, J ;
Heinzmann, A ;
Kuehr, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 231 (03) :696-697
[10]   Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions [J].
deRosbo, NK ;
Hoffman, M ;
Mendel, I ;
Yust, I ;
Kaye, J ;
Bakimer, R ;
Flechter, S ;
Abramsky, O ;
Milo, R ;
Karni, A ;
BenNun, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (11) :3059-3069